(Q47268210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

Niina Hanna Talvikki Matikainen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Marja-Riitta Taskinen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

N Matikainen

1

1 reference

http://europepmc.org/abstract/MED/23215876

12 January 2018

M-R Taskinen

2

1 reference

http://europepmc.org/abstract/MED/23215876

12 January 2018

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

756-757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states

19 February 2020

cites work

1 reference

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

21 January 2018

1 reference

Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.

21 January 2018

1 reference

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

21 January 2018

1 reference

One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress

21 January 2018

1 reference

Type 2 diabetes across generations: from pathophysiology to prevention and management

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DME.12094

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215876%20AND%20SRC:MED&resulttype=core&format=json